# Tranexamic Acid and Thromboelastography During Cesarean Delivery

> **NCT02026297** · PHASE2 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 60 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Placebo; Normal Saline

## Key facts

- **NCT ID:** NCT02026297
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2015-07
- **Final completion:** 2020-02-21
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** funding and manpower unavailable, completion within a reasonable timeframe not possible.
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02026297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02026297, "Tranexamic Acid and Thromboelastography During Cesarean Delivery". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02026297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*